[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523951":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":27,"locations":33,"responsibleParty":51,"collaborators":24,"id":55,"slug":24,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":24,"eligibilityCriteria":59,"healthyVolunteers":56,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":74,"overallStatus":36,"whyStopped":24,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Norepinephrine (0.1)","EXPERIMENTAL","An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.1 µg\u002Fkg\u002Fmin till 5 minutes after delivery of the fetus.",[13],"Drug: Norepinephrine (0.1)",{"label":15,"type":16,"description":17,"interventionNames":18},"Norepinephrine (0.075)","ACTIVE_COMPARATOR","An intravenous bolus dose of norepinephrine (5 µg) followed by infusion of 0.075 µg\u002Fkg\u002Fmin till 5 minutes after delivery of the fetus.",[19],"Drug: Norepinephrine (0.075)",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":26,"otherNames":24},[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":24,"email":32},"Zakaria A. Zakaria","CONTACT","+201150637566","za6841924@gmail.com",[34],{"facility":35,"status":36,"city":37,"state":24,"zip":24,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Assiut University Woman Health Hospital","RECRUITING","Asyut","Egypt",{"type":40,"coordinates":41},"Point",[42,43],31.18368,27.18096,{"lat":43,"lon":42},[46,48],{"name":47,"role":30,"phone":24,"phoneExt":24,"email":32},"Zakaria Ah. Zakaria",{"name":49,"role":30,"phone":24,"phoneExt":24,"email":50},"Hany M. Osman, M.D.","hanymeo@aun.edu.eg",{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Zakaria Ahmed Zakaria","Principal Investigator","100523951",false,"NCT06102382","The Effect of Two Different Doses of Noradrenaline on Hypotension Caused by Spinal Anesthesia for Cesarean Section","Inclusion Criteria:\n\n* Pregnant women scheduled for cesarean section under spinal anesthesia\n* Gestational age of at least 37 weeks\n\nExclusion Criteria:\n\n* Patient refusal\n* Contraindications of spinal anesthesia\n* Allergy to the study drug\n* Height\\\u003C150 cm, weight \\\u003C 60 kg, body mass index (BMI) ≥40 kg\u002Fm2.\n* patients with cardiac morbidities\n* Hypertensive disorders of pregnancy.\n* Prepartum hemorrhage","FEMALE","19 Years","40 Years",{"count":64,"type":65},100,"ESTIMATED","INTERVENTIONAL",[68],"NA","To compare two infusion rates of norepinephrine for prophylaxis against post-spinal hypotension during caesarean delivery.",[71,72,73],"Cesarean Section","Hypotension","Norepinephrine",[73,75,72,76],"Spinal anesthesia","Cesarean section","2025-08-24",{"date":79,"type":80},"2025-08-29","ACTUAL",{"date":82,"type":80},"2024-09-01",{"date":84,"type":65},"2025-12-01",{"name":5,"class":6},1]